Aktuellt
SENASTE
The Q1 report provided further encouraging signs of improving performance for Bactiguard and reaffirmed our view of Q3/20 being the trough. Broader vaccinations and a gradually increasing general healthcare occupancy will not only lead to improving performance of Bactiguard’s current business but also intensify ongoing discussions for further licence agreements in further product categories, we believe.
LÄS MER
